According to Vademecum, the Ministry of Industry and Trade of the Russian Federation has submitted for public discussion a draft decree of the Government of the Russian Federation on the rules for providing state support to domestic industrial organizations, including pharmaceutical, in order to compensate for product transportation costs. The discussion of the project will last until May 25.
The Russian Export Center (REC) will provide subsidies from the federal budget to reduce the costs of companies when transporting goods. If the document is approved, pharmaceutical industry organizations will be able to receive subsidies in the amount of 30% of their product transportation costs starting from January 2023.
According to the draft document, the costs to be compensated are going to be those incurred by manufacturers, their affiliated persons and other authorized representatives under product supply contracts specified in the agency agreement.
Subsidies can be provided to Russian companies that do not have tax debt or other payments in arrears to the federal budget. They must also have no signs of bankruptcy or management disqualification. The maximum share of foreign capital participation must not exceed 50%.
If approved, the support measures will be in effect until December 31, 2024.
As it became known earlier, Russian importers, including importers of medicines and pharmaceutical products, will be able to take advantage of a special program of preferential loans.